← SynDRA
EPRENETAPOPT
SynDRA canonical compound SYN0037942 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
|---|
| Primary target(s) | TP53 |
|---|
| Mechanism of action | p53 activator |
|---|
All known targets
Mechanisms of action (all sources)
- TP53 STABILISER
- Cellular tumor antigen p53 stabiliser
- TP53 ACTIVATOR
- TP53 STIMULATOR
Cross-references
Synonyms
- APR-246
- PRIMA-1Met
- APR 246
- Z41TGB4080
- 3-Quinuclidinone, 2-(hydroxymethyl)-2-(methoxymethyl)-
- PRIMA-1(MET)
- RefChem:137402
- DTXCID501595463
- Prima 1MET
- 2-(Hydroxymethyl)-2-(methoxymethyl)quinuclidin-3-one
- Eprenetapopt [USAN]
- MFCD20620963
- Eprenetapopt (USAN)
- UNII-Z41TGB4080
- EPRENETAPOPT [INN]
- MLS006010767
- EPRENETAPOPT [WHO-DD]
- APR246
- orb1302879
- SCHEMBL2228161
- SCHEMBL21636035
- SCHEMBL28990158
- APR-246 (PRIMA-1MET)
- GLXC-03565
- PRIMA-1MET(APR-246)?
- EX-A2772
- MFCD16294187
- NSC791496
- s7724
- WHO 11387
- AKOS024457764
- CCG-266578
- CS-7614
- NSC-791496
- SB19737
- NCGC00346881-01
- NCGC00346881-04
- AC-32964
- AS-72033
Look up EPRENETAPOPT in the interactive SynDRA portal →